Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new Revision: v3.7.0 was added to the revision history, and the previous Revision: v3.6.6 was removed, updating the page's revision record.
    Difference
    0.0%
    Check dated 2026-09-15T21:43:52.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study record was updated to revision v3.6.6, indicating a new version of the ClinicalTrials.gov entry with likely administrative or QC updates to the record.
    Difference
    0.0%
    Check dated 2026-09-01T18:26:18.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a new entry in the study's external identifiers: '2017 ( U.S. NIH Grant/Contract )'. This links the study to a U.S. NIH grant/contract as part of the Other Study ID Numbers field, enriching funding attribution.
    Difference
    0.0%
    Check dated 2026-08-25T19:46:03.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page was published. This appears to be a backend or documentation update rather than a substantive modification to the study details or visible content.
    Difference
    0.0%
    Check dated 2026-08-11T19:31:52.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    - A new publication citation was added to the Publications section: Silverberg JI, Prajapati VH, Abraham S, Irvine AD, Gooderham MJ, Guttman-Yassky E, Tanizaki H, Rademaker M, Chen SH, Moreira A, Ta R, Lee WJ, Eyerich K. Achieving Minimal Disease Activity in Atopic Dermatitis Is Associated with Fewer Flares, Reduced Healthcare Resource Utilization, and Improved Disease Control: Analysis from the Real-World MEASURE-AD Study. Dermatol Ther (Heidelb). 2026 Jul 30. Online ahead of print.
    Difference
    0.0%
    Check dated 2026-08-04T16:32:38.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page's revision identifier was updated to v3.6.4, signaling a platform or content release update. This update does not modify study details, eligibility criteria, or displayed results.
    Difference
    0.0%
    Check dated 2026-07-21T12:39:21.000Z thumbnail image

Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.